FVAV

Fortress Value Acquisition

• PUBT·05/27 20:28

  Fortress Value Acquisition V appoints Karen Park to board, audit and compensation committees

• PUBT·05/27 20:24

  Fortress Value Acquisition Sponsor V reports $104.35 disposal of Fortress Value Acquisition Corp. V common shares

• PUBT·05/27 20:22

  Fortress Value Acquisition V director Karen Sunhyon Park files initial beneficial ownership statement

• PUBT·04/30 21:39

  Fortress Value Acquisition V swings to Q1 profit of $0.8 million

• Reuters·03/09 17:19

  FORTRESS VALUE ACQUISITION CORP. V ANNOUNCES CLOSING OF FULLY-EXERCISED OVER-ALLOTMENT OPTION IN CONNECTION WITH ITS INITIAL PUBLIC OFFERING

• TipRanks·03/02 16:30

  Opening Day: Generate Biomedicines makes public debut

• Seeking Alpha·02/28 02:25

  U.S. IPO Weekly Recap: Asthma-Focused Generate Biomedicines Closes Out February IPO Market

• Reuters·02/27 19:01

  FORTRESS VALUE ACQUISITION CORP. V ANNOUNCES CLOSING OF $250,000,000 INITIAL PUBLIC OFFERING